Omniab, INC Form 4 insider transactions

Amechi Ekeke Nwachuku, Chief Operating Officer of OmniAb, Inc., received 800,000 shares of common stock on August 1, 2026.

OmniAb, Inc. Director Carolyn R. Bertozzi reported transactions involving common stock, restricted stock units, and stock options on June 17, 2026.

OmniAb, Inc. Director Jennifer R. Cochran acquired 20,000 shares through RSU vesting and was granted 40,000 stock options.

OmniAb, Inc. Director Steven C. Crouse reported transactions involving common stock, restricted stock units, and stock options.

OmniAb, Inc. Director Philip J. Gotwals reported transactions involving common stock, restricted stock units, and stock options on June 17, 2026.

OmniAb, Inc. Director John L. Higgins reported transactions involving the acquisition of 20,000 Restricted Stock Units and 40,000 Stock Options.

OmniAb, Inc. Director Steven Love reported transactions involving common stock, restricted stock units, and stock options on June 17, 2026.

OmniAb, Inc. Director Philip J. Gotwals reported the vesting of 13,333 Restricted Stock Units (RSUs) on April 21, 2026, as per SEC Form 4 filing.

OmniAb, Inc. director Steven C. Crouse reported the vesting of 13,333 Restricted Stock Units (RSUs) on April 21, 2026, as part of a three-year installment plan.

OmniAb President and CEO Matthew Foehr acquired 36,459 shares through RSU vesting, with a mandatory portion sold to cover tax obligations.

OmniAb's Executive VP of Finance and CFO Kurt Gustafson acquired 13,542 shares through RSU vesting and sold 6,913 shares to satisfy mandatory tax obligations.

OmniAb's Chief Legal Officer Charles Berkman acquired 13,542 shares through RSU vesting and sold 7,157 shares to cover mandatory tax obligations.

OmniAb's Chief Legal Officer, Charles S. Berkman, reported significant equity transactions including RSU vesting, tax-related share sales, and new grants of RSUs and stock options.

OmniAb's Executive VP, Finance and CFO, Kurt A. Gustafson, reported the vesting of restricted stock units, a tax-related share sale, and new grants of restricted stock units and stock options.

OmniAb, Inc.'s President and CEO, Matthew W. Foehr, reported the vesting of restricted stock units, a sell-to-cover transaction for taxes, and new grants of restricted stock units and stock options.

OmniAb, Inc. Director John L. Higgins reported the vesting of 13,172 Restricted Stock Units on January 30, 2026, increasing his direct common stock holdings.

OmniAb's Chief Legal Officer, Charles S. Berkman, reported the vesting of 15,621 Restricted Stock Units and a subsequent sale of 8,044 shares to cover tax obligations.

OmniAb's Executive VP, Finance and CFO, Kurt A. Gustafson, reported the vesting of 46,500 Restricted Stock Units and a subsequent sale of 23,922 shares to cover tax obligations.

OmniAb's President and CEO, Matthew W. Foehr, reported the vesting of restricted stock units and a subsequent sell-to-cover transaction for tax obligations.

OmniAb Director John L. Higgins acquired additional common stock in two separate transactions in early November 2025.

OmniAb Director Carolyn R Bertozzi reported the scheduled vesting of 17,769 Restricted Stock Units into common stock on November 1, 2025.

OmniAb Director Steven Love reported the vesting of 13,333 Restricted Stock Units, increasing his direct beneficial ownership of common stock.

OmniAb, Inc. President and CEO Matthew W. Foehr acquired 540,540 shares of common stock in a private placement, increasing his beneficial ownership.

OmniAb, Inc. Director Steven Love has reported the vesting of Restricted Stock Units and the acquisition of new equity awards, including additional RSUs and stock options, according to a recent SEC Form 4 filing.

OmniAb, Inc. Director John L. Higgins reported the vesting of 20,000 Restricted Stock Units and the acquisition of 20,000 new Restricted Stock Units and 40,000 Stock Options on June 17, 2025, increasing his beneficial ownership.

OmniAb, Inc. Director Philip J. Gotwals was granted 20,000 Restricted Stock Units and 40,000 Stock Options, aligning his interests with shareholders.

OmniAb, Inc. Director Steven C. Crouse was granted 20,000 Restricted Stock Units and 40,000 stock options on June 17, 2025, as disclosed in a recent SEC Form 4 filing.

OmniAb, Inc. Director Jennifer R. Cochran reported an increase in her beneficial ownership of common stock following the vesting of restricted stock units and the grant of new equity awards.

OmniAb, Inc. Director Carolyn R. Bertozzi has reported the vesting of 20,000 Restricted Stock Units (RSUs) into common stock, alongside the acquisition of 20,000 new RSUs and 40,000 stock options, aligning her interests with the company's future performance.

Director Jennifer Cochran purchased 30,000 shares of OmniAb, Inc. at an average price of $1.52 on May 15, 2025.